Welcome to our dedicated page for Amrize SEC filings (Ticker: AMRZ), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Amrize Ltd (NYSE: AMRZ) SEC filings page on Stock Titan provides access to the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents. As a Switzerland-incorporated issuer listed on the New York Stock Exchange and the SIX Swiss Exchange, Amrize files reports with the U.S. Securities and Exchange Commission that give investors structured information about its operations and financial condition.
Recent Form 8-K filings from Amrize have reported quarterly financial results and related investor materials. These filings typically reference earnings press releases and investor presentations that discuss revenue by segment, non-GAAP metrics such as Adjusted EBITDA, Free Cash Flow, Net Debt and Net Leverage Ratio, and commentary on the performance of the Building Materials and Building Envelope segments. They also confirm details such as the company’s jurisdiction of incorporation in Switzerland and its principal executive office location in Zug.
On this page, investors can monitor new 8-K filings as they are released, along with other SEC forms when available, such as annual and quarterly reports that provide more comprehensive detail on Amrize’s business, risk factors and segment information. Filings related to capital structure, such as debt issuance, and any documents reporting significant events or transactions, are also part of the regulatory record.
Stock Titan enhances these filings with AI-powered summaries designed to explain the main points of lengthy documents in clear language. This can help readers quickly understand key topics such as segment performance, changes in leverage, major investments, or strategic initiatives like the ASPIRE program, while still allowing direct access to the full original filings for detailed analysis.
Amrize Ltd is appointing Baris Oran as Chief Financial Officer effective April 1, 2026, succeeding long‑time CFO Ian Johnston, who will remain as a senior advisor to support the transition and will be on garden leave until March 31, 2027. The company states that Johnston’s change in role is not related to any disagreement on financial controls, reporting, operations, policies, or practices.
Oran, formerly CFO of GXO Logistics, XPO Logistics and the Sabanci Group, will receive an annual base salary of $750,000, target annual bonus equal to 100% of salary with a maximum of 200%, and long‑term equity grants targeted at least 325% of salary. His package also includes a $29,000 annual car allowance, standard benefits, and relocation support under an employment agreement with a 12‑month termination notice period and no cash change‑of‑control payments. Amrize highlights its 2025 revenue of $11.8 billion and strong balance sheet as it brings in Oran to help drive profitable growth.
Amrize Ltd amendment shows The Vanguard Group reports no beneficial ownership of Common Stock. The Schedule 13G/A amendment states an amount beneficially owned: 0 and percent of class: 0%. The filing explains an internal realignment on January 12, 2026 that caused certain Vanguard subsidiaries to report separately under SEC Release No. 34-39538.
The filing is signed by Ashley Grim as Head of Global Fund Administration on March 26, 2026.
Amrize Ltd President, Building Envelope James J. Gosa reported a routine tax-withholding transaction involving 14,541 Ordinary Shares at $52.56 per share. These shares were withheld to satisfy tax obligations rather than sold on the open market. After this disposition, he directly holds 41,268 Ordinary Shares, which include 170 shares acquired under the Amrize Ltd 2025 Employee Stock Purchase Plan on December 31, 2025.
Amrize Ltd’s Chief Supply Chain Officer, Mario Gross, made open-market purchases of the company’s Ordinary Shares. On March 13, 2026, he bought a total of 3,200 shares in two transactions, acquiring 2,000 shares at $55.39 per share and 1,200 shares at $55.13 per share. After these purchases, his direct ownership increased to 30,947 Ordinary Shares. The footnotes state the trades were executed in Swiss Francs at prices of CHF 43.665 and CHF 43.46 per share, converted into U.S. dollars using an exchange rate of USD 1.00 = CHF 0.7883.
Amrize Ltd Chief Technology Officer Brouwer Roald bought 2,000 ordinary shares in an open-market transaction. The purchase was made on March 13, 2026 at a reported price of $54.88 per share, increasing his direct holdings to 18,257 shares.
The transaction was executed in Swiss Francs at a price of CHF 43.26 per share and converted into U.S. dollars using the transaction-date exchange rate of USD 1.00 = CHF 0.7883, as disclosed in the footnote.
Amrize Ltd has called its 2026 Annual General Meeting for April 21, 2026 in Zug, Switzerland, asking shareholders to vote on a wide slate of financial, compensation and governance items. Shareholders are asked to approve the 2025 Annual Report, including Consolidated and Statutory Financial Statements, and an offset of accumulated losses totaling USD 102,256,906 using legal retained earnings and capital reserves.
The Board proposes a special one‑time cash distribution of USD 0.44 per outstanding share from capital contribution reserves and a regular dividend of up to USD 0.44 per share in up to four installments, capped at an aggregate USD 250,657,000. Advisory votes cover U.S.‑style say‑on‑pay, Swiss statutory remuneration, a Non‑Financial Matters Report on environmental and social topics, and the preferred annual frequency of say‑on‑pay.
Binding votes include discharging directors and executives from liability for 2025, re‑electing nine current directors and electing two new ones for one‑year terms, re‑electing Jan Jenisch as Chairman, choosing Compensation Committee members, and approving maximum aggregate compensation of USD 3,600,000 for the Board (2026–2027 term) and USD 59,000,000 for Executive Management for fiscal 2027. Shareholders are also asked to re‑elect Ernst & Young AG as statutory auditor, ratify Ernst & Young LLP as U.S. auditor for 2026, and appoint Advoro Zurich Ltd as Independent Voting Representative, alongside detailed instructions on record dates, proxy voting and meeting attendance.
Amrize Ltd executive Jaime Hill, President, Building Materials, bought 1,000 Ordinary Shares in an open-market transaction at $56.90 per share. After this purchase, Hill directly owns 28,000 Ordinary Shares, indicating a modest increase in personal equity exposure to the company.
Amrize Ltd's Chief Financial Officer, Ian A. Johnston, bought ordinary shares in the company in an open-market transaction. He acquired 4,250 ordinary shares at a price of $58.935 per share. Following this purchase, he directly owns 25,110 ordinary shares of Amrize Ltd.
Amrize Ltd executive Jaime Hill, President, Building Materials, bought 1,000 Ordinary Shares in an open-market purchase. The shares were acquired at a price of $58.91 per share. Following this transaction, Hill directly owns a total of 27,000 Ordinary Shares of Amrize.